Each filer's latest filing for 26253C201 since 12/18/2024, largest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Heng Fai Ambrose Chan
13D/A
|
86.3% |
9/8/2026
Event 9/3/2026
|
|
| Heng Fai Ambrose Chan | 86.3% | ||
| Alset Inc. | 80.0% | ||
| Global Biomedical Pte. Ltd. | 3.1% | ||
| Alset International Limited | 71.0% |
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 3 | 4.00 | $2.00 |
| 2026 Q2 | 17 | 427 k | $252 k |
| 2026 Q1 | 18 | 225 k | $187 k |
| 2025 Q4 | 17 | 159 k | $148 k |
| 2025 Q3 | 15 | 146 k | $197 k |
| 2025 Q2 | 19 | 164 k | $154 k |
| 2025 Q1 | 15 | 165 k | $143 k |
| 2024 Q4 | 15 | 122 k | $110 k |
| 2024 Q3 | 13 | 172 k | $219 k |
| 2024 Q2 | 16 | 183 k | $315 k |
| 2024 Q1 | 16 | 163 k | $295 k |